Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP29-02 (Dymista) in Seasonal Allergic Rhinitis
NCT00883168Phase 3Completed
- Sponsor
- Meda
- Start
- Apr 2009
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine, fluticasone propionate in seasonal allergic rhinitis (SAR), sponsored by Meda. Started Apr 2009; status: completed.
02
Drugs
azelastinefluticasone propionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00883168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883168.